Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stoter

Showing results (121-130 of 249) with videos related to

Pageof 25
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Efficacy and side effects of two chemotherapy regimens with cisplatin plus fluorouracil in advanced squamous cell carcinoma of the head and neckA S Planting, C K van Sichem, P I Schmitz, et al.
Journal of the National Cancer Institute|October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor supportR de Wit, J Verweij, M Bontenbal, et al.
Analytical Biochemistry|August 26, 1998
Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusionsE Brouwer, J Verweij, B Hauns, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed KliniekG Stoter, S H Goey, A M Eggermont, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|February 12, 2000
Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatographyW J Loos, P de Bruijn, L van Zuylen, et al.
Analytical Biochemistry|March 30, 1999
Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatographyP de Bruijn, M J de Jonge, J Verweij, et al.
Clinical and Experimental Immunology|May 1, 1993
Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2J W Gratama, R J Bruin, C H Lamers, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative studyL C Pronk, W L van Putten, V van Beurden, et al.
Leukemia|June 1, 1994
Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemiasH Burger, K Nooter, G J Zaman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Pageof 25

Showing results (121-130 of 249) with videos related to

Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Efficacy and side effects of two chemotherapy regimens with cisplatin plus fluorouracil in advanced squamous cell carcinoma of the head and neckA S Planting, C K van Sichem, P I Schmitz, et al.
Journal of the National Cancer Institute|October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor supportR de Wit, J Verweij, M Bontenbal, et al.
Analytical Biochemistry|August 26, 1998
Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusionsE Brouwer, J Verweij, B Hauns, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed KliniekG Stoter, S H Goey, A M Eggermont, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|February 12, 2000
Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatographyW J Loos, P de Bruijn, L van Zuylen, et al.
Analytical Biochemistry|March 30, 1999
Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatographyP de Bruijn, M J de Jonge, J Verweij, et al.
Clinical and Experimental Immunology|May 1, 1993
Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2J W Gratama, R J Bruin, C H Lamers, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative studyL C Pronk, W L van Putten, V van Beurden, et al.
Leukemia|June 1, 1994
Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemiasH Burger, K Nooter, G J Zaman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Pageof 25